deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02918305

Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant Hypertension (REQUIRE)

A Clinical Study of the Ultrasound Renal Denervation System in Patients With Resistant Hypertension

Sponsor: JIMRO Co., Ltd.

Conditions Hypertension Vascular Diseases
Interventions PRDS-001 Renal Denervation Ultrasound System Sham Procedure
Updated 15 times since 2017 Last updated: Nov 11, 2021 Started: Jan 31, 2017 Primary completion: Jul 31, 2020 Completion: Oct 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Hypertension and Vascular Diseases, this trial is completed. The trial is conducted by JIMRO Co., Ltd. and has accumulated 15 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2017 – ~Oct 2017 · 9 months · monthly snapshot~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Jun 2019 · 9 months · monthly snapshot~Jun 2019 – ~Mar 2020 · 9 months · monthly snapshot~Mar 2020 – ~Sep 2020 · 6 months · monthly snapshot~Sep 2020 – ~Dec 2020 · 3 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  5. Sep 2021 — Dec 2021 [monthly]

    Active Not Recruiting PHASE3

▶ Show 10 earlier versions

  1. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE3

  2. Dec 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  3. Sep 2020 — Dec 2020 [monthly]

    Recruiting PHASE3

  4. Mar 2020 — Sep 2020 [monthly]

    Recruiting PHASE3

  5. Jun 2019 — Mar 2020 [monthly]

    Recruiting PHASE3

  6. Sep 2018 — Jun 2019 [monthly]

    Recruiting PHASE3

  7. Aug 2018 — Sep 2018 [monthly]

    Recruiting PHASE3

  8. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE3

  9. Oct 2017 — Jun 2018 [monthly]

    Recruiting PHASE3

  10. Jan 2017 — Oct 2017 [monthly]

    Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • JIMRO Co., Ltd.
Data source: JIMRO Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adachi City, Japan , Amagasaki, Japan , Busan, South Korea , Chikushino-shi, Japan , Chiyoda City, Japan , Daegu, South Korea , Daejeon, South Korea , Fukuoka, Japan , Gangneung, South Korea , Gwangju, South Korea and 43 more locations